Since its inception, Tesla (NASDAQ:TSLA) has been defying norms and pushing boundaries. Its ambitious mission to “accelerate the world’s transition to sustainable energy” has propelled it to the forefront of the global EV industry. However, the TSLA stock narrative extends beyond its prowess in EV manufacturing. Its foray into areas such as autonomous driving technology,
0 Comments
Technology stocks have staged a comeback for the ages. After being the worst performing asset class in 2022 during what became known as the “tech wreck,” shares of technology stocks have rallied big time this year, fueled in large part by the hype surrounding artificial intelligence (AI). Consider that, in 2022, the tech-laden Nasdaq index
0 Comments
Artificial intelligence (AI) stocks are likely to become even stronger potential investments as AI has begun playing a significant role in cybersecurity. AI allows professionals to quickly and accurately analyze huge amounts of data. This was exemplified by retired U.S. Army General Stanley McChrystal’s company predicting Russian’s 2022 evasion of the Ukraine with the usage
0 Comments
With the market surging, investors might think that the best opportunities have passed them by. But don’t fear, there are still many worthwhile undervalued stocks to buy today. In fact, these three companies all have proven business models, strong customer bases and pay attractive dividends. For investors looking for a bargain, these are three of
0 Comments
Global real GDP growth was robust at 3.4% last year. However, with policy tightening and geopolitical tensions, growth is likely to ease to 2.8% in 2023. Further, the International Monetary Fund expects GDP growth to accelerate to 3% in the coming year. Considering the data, global recession fears have declined meaningfully. Therefore, I believe it’s a
0 Comments
The Nasdaq index rebalancing will change the weights of key stocks within the fund. Big tech stocks will have a lower concentration within the index. Some investors believe the rebalance is long overdue, with six stocks currently markup up 50% of the Nasdaq 100’s assets. The index rebalancing will reduce these corporations to 40% of the
0 Comments
The biotech industry is constantly evolving due to being on the cutting edge of the healthcare industry’s research and development. Large biotech companies such as Johnson and Johnson (NYSE:JNJ), Merck (NYSE:MRK), and AbbVie (NYSE:ABBV) offer investors steady and continual growth as well as decent dividends. But, a large portion of the industry involves much more
0 Comments
Blue-chip stocks offer investors equity in established, financially sound firms with strong reputations. They’re generally market leaders and tend to be household names familiar to those outside the investing world. In short, they’re likely to provide returns to investors in almost every case.  Blue-chip stocks often include dividends and are known for reliable earnings. That
0 Comments